Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
48.10
-0.31 (-0.64%)
Aug 24, 2026, 3:04 PM CST

Intco Medical Technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
4,3775,94812,0147,2225,0335,003
Short-Term Investments
---723.211,613-
Trading Asset Securities
10,7537,2436,7375,2361,6243,274
Cash & Short-Term Investments
15,13013,19118,75113,1818,2708,277
Cash Growth
-33.04%-29.65%42.26%59.39%-0.09%29.52%
Accounts Receivable
1,4041,3711,379937.18555.36775.15
Other Receivables
118.6846.0878.3341.8980.9330.6
Receivables
1,5231,4171,457979.08636.29805.75
Inventory
2,0531,3271,2651,1501,0041,079
Other Current Assets
397.12363.99480.62292.93325.23600.95
Total Current Assets
19,10316,29921,95515,60310,23510,763
Property, Plant & Equipment
11,51911,6079,7909,2468,9118,262
Long-Term Investments
8,92110,4611,382970.38884.94473.89
Other Intangible Assets
698.86729.1767.03566.84583.48629.91
Long-Term Deferred Tax Assets
58.7851.6180.3564.0988.3177.23
Long-Term Deferred Charges
4.774.925.221.841.762.9
Other Long-Term Assets
937.61937.67651.63627.32774.31415.84
Total Assets
41,24340,09034,63127,07921,47920,625

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,5041,257845.38921.6946.361,238
Accrued Expenses
140.56234.47215.38174.47201.53194
Short-Term Debt
16,77916,39012,6667,0341,49450.48
Current Portion of Long-Term Debt
248.7701.44436.3753.429.0434.29
Current Portion of Leases
---1.944.012.64
Current Income Taxes Payable
248.2116.4165.1815.649.6337.5
Current Unearned Revenue
260.23237271.58293.6300.89414.16
Other Current Liabilities
285.37241.9182.41123.67169.43113.07
Total Current Liabilities
19,46619,17814,6838,6183,1552,084
Long-Term Debt
451.33409.29166.877.2551.59201.26
Long-Term Leases
----1.783.38
Long-Term Unearned Revenue
210.42211.99155.84123.99128.53201.02
Long-Term Deferred Tax Liabilities
1,7281,7191,9441,9652,0932,012
Total Liabilities
21,85621,51916,94910,7855,4294,501

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
654.75654.75646.19656659.55549.58
Additional Paid-In Capital
1,2121,1831,1141,2871,3101,509
Retained Earnings
17,46416,69215,77814,39614,07213,855
Treasury Stock
-239.12-239.12-133.47-320.55-253.81-27.76
Comprehensive Income & Other
-92.41-36.68-0.3810.6318.79-15.22
Total Common Equity
19,00018,25417,40416,02915,80615,871
Minority Interest
386.77318.06277.6265.99242.93252.25
Shareholders' Equity
19,38718,57217,68216,29516,04916,123
Total Liabilities & Equity
41,24340,09034,63127,07921,47920,625

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
17,47917,50113,2697,1661,580292.05
Net Cash (Debt)
-2,349-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-3.62-6.698.459.1110.1011.82
Filing Date Shares Outstanding
776.84646.16641.39643.38659.55659.49
Total Common Shares Outstanding
776.84646.16641.39643.38659.55659.49
Working Capital
-363.32-2,8797,2726,9857,0808,679
Book Value Per Share
24.4628.2527.1424.9123.9724.07
Tangible Book Value
18,30117,52516,63715,46215,22315,241
Tangible Book Value Per Share
23.5627.1225.9424.0323.0823.11
Land
-11.7211.7211.7211.5210.55
Buildings
-5,8874,5574,0573,4802,400
Machinery
-8,4716,6245,6134,9864,247
Construction In Progress
-803.111,2881,5091,7052,326